These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3056807)

  • 21. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
    Giugliano D; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substitution of basal delivery of insulin by proinsulin in type I diabetic patients under CSII.
    Kerner W; Wallmüller G; Beischer W; Pfeiffer EF
    Horm Metab Res Suppl; 1988; 18():74-7. PubMed ID: 3056816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biosynthetic human insulin: pharmacokinetics and effects in healthy human volunteers.
    Brogard JM; Blickle JF; Pinget M; Stahl A; Dorner M
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):575-80. PubMed ID: 6360919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma adiponectin is modestly decreased during 24-hour insulin infusion but not after inhibition of lipolysis by Acipimox.
    Dullaart RP; Riemens SC; Meinardi JR; Wolffenbuttel BH; Sluiter WJ
    Scand J Clin Lab Invest; 2005; 65(6):523-31. PubMed ID: 16179286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
    Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M
    J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoglycemic potency and metabolic clearance rate of intravenously administered human proinsulin and metabolites.
    Tillil H; Frank BH; Pekar AH; Broelsch C; Rubenstein AH; Polonsky KS
    Endocrinology; 1990 Nov; 127(5):2418-22. PubMed ID: 2226325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of new hypoglycemic agent A-4166 on lipolysis and lipogenesis in rat adipocytes.
    Macho L; Fickova M; Zorad S; Sebokova E; Klimes I
    Endocr Regul; 2000 Sep; 34(3):119-26. PubMed ID: 11074662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of comparative perfusions of equimolar, single component insulin and proinsulin in the human forearm.
    Fineberg SE; Merimee TJ
    Diabetes; 1973 Sep; 22(9):676-86. PubMed ID: 4728207
    [No Abstract]   [Full Text] [Related]  

  • 29. Biosynthetic human insulin and proinsulin have additive but not synergistic effects on total body glucose disposal.
    Revers RR; Henry R; Schmeiser L; Kolterman O; Cohen R; Rubenstein A; Frank B; Galloway J; Olefsky JM
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1094-8. PubMed ID: 6373809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabolic effects of biosynthetic human proinsulin in individuals with type I diabetes.
    Bergenstal RM; Cohen RM; Lever E; Polonsky K; Jaspan J; Blix PM; Revers R; Olefsky JM; Kolterman O; Steiner K
    J Clin Endocrinol Metab; 1984 Jun; 58(6):973-9. PubMed ID: 6373814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of biosynthetic human proinsulin on the hepatic response to glucagon in insulin-deficient diabetes.
    Cohen RM; Licinio J; Polonsky KS; Galloway JA; Frank BH; Cherrington AD; Rubenstein AH
    J Clin Endocrinol Metab; 1987 Mar; 64(3):476-81. PubMed ID: 3546347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of proinsulin pretreatment on the combined actions of insulin and proinsulin in normal man.
    Glauber HS; Wallace P; Galloway J; Frank BH; Olefsky JM
    J Clin Endocrinol Metab; 1986 Apr; 62(4):785-8. PubMed ID: 3512594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of biosynthetic human diarginylinsulin.
    Zeuzem S; Stahl E; Jungmann E; Zoltobrocki M; Schöffling K; Caspary WF
    Diabetologia; 1990 Feb; 33(2):65-71. PubMed ID: 2184062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of biosynthetic human proinsulin on carbohydrate metabolism.
    Revers RR; Henry R; Schmeiser L; Kolterman O; Cohen R; Bergenstal R; Polonsky K; Jaspan J; Rubenstein A; Frank B
    Diabetes; 1984 Aug; 33(8):762-70. PubMed ID: 6378699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic effects of a single administration of growth hormone on lipid and carbohydrate metabolism in normal-weight and obese subjects.
    Seng G; Galgoti C; Louisy P; Toussain P; Drouin P; Debry G
    Am J Clin Nutr; 1989 Dec; 50(6):1348-54. PubMed ID: 2596425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the lipolytic effects of insulin and proinsulin on isolated fat cells.
    Lavis VR; Williams RH
    Diabetes; 1975 Feb; 24(2):238-9. PubMed ID: 1123111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro characterization of biosynthetic human proinsulin.
    Podlecki DA; Frank BH; Olefsky JM
    Diabetes; 1984 Feb; 33(2):111-8. PubMed ID: 6363165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study on the metabolism of human insulin and porcine proinsulin in man.
    Sönksen PH; Tompkins CV; Srivastava MC; Nabarro JD
    Clin Sci Mol Med; 1973 Nov; 45(5):633-54. PubMed ID: 4796692
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypoglycemic action of porcine proinsulin in eviscerated, functionally hepatectomized rats.
    Penhos JC; Voyles N; Lazarus N; Tanese T; Gutman R; Recant L
    Horm Metab Res; 1970 Jan; 2(1):43-4. PubMed ID: 5520751
    [No Abstract]   [Full Text] [Related]  

  • 40. Lack of hypoglycemic effect of bovine proinsulin in eviscerated, hepatectomized rats.
    Willms B; Appels A; Söling HD; Creutzfeldt W
    Horm Metab Res; 1969 Jul; 1(4):199-200. PubMed ID: 5407082
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.